Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440180
Status:
TERMINATED
Last Update Posted:
2016-04-06
First Post:
2007-02-22
Brief Title:
Aromatase Inhibitors in the Treatment of Male Infertility
Sponsor:
University of Utah
Organization:
University of Utah
Study Overview
Official Title:
The Role of Aromatase Inhibitors in the Treatment of Infertility in Obese Male
Status:
TERMINATED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not able meet target enrollment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Obesity is associated with an increase in blood levels of estrogen Estrogen or female hormone is believed to have a negative effect on sperm production Aromatase inhibitors such as anastrozole work to decrease the production of estrogen and increase testosterone in the body By decreasing the level of estrogen sperm production should improve In this study the investigators will try to determine the benefit of anastrozole in obese men and follow pregnancy outcomes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None